Clinical trials recruiting for Adult Solid Tumor
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Carboplatin (AUC 5) | 1 |
| DO-2 | 1 |
| Docetaxel | 1 |
| Nivolumab | 1 |
| Pembrolizumab 200 mg Q3W | 1 |
| Pemetrexed 500 mg/m^2 | 1 |
| Visugromab | 1 |
| Visugromab 6mg/kg | 1 |
| Visugromab RDE (recommended dose for expansion) | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Alabama | 2 |
| California | 2 |
| New York | 2 |
| North Carolina | 2 |
| Connecticut | 1 |
| Florida | 1 |
| South Carolina | 1 |
Top cities
Self-screener
Recruiting trials
- Study to Determine the Safety and Pharmacokinetics of DO-2 in Patients With Advanced or Refractory Solid Tumours
- Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLC
- Trial Investigating Visugromab in Combination With Immunochemotherapy in 1L Treatment of Participants With Metastatic NSCLC
Related conditions
Trials recruiting for Adult Solid Tumor often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Adult Solid Tumor trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.